Clearing the path by understanding the obstacles: The 2017 Sharing Conference
The Sharing Conference returns to Baltimore in 2017
Patient data saves lives
MDM’s growing role in running healthcare businesses
The pharma industry has a growing number of dependencies on reliable master data
The power of strategic data standardization
Global efforts to collect clinical data in a more standardized form will lead to more research innovation
2017 Cold Chain Outlook
“Cold chain” now means cryogenic and ambient shipping, as well as the traditional 2–8° range
Cold Chain 2017 Directory
Is the opioid crisis a national emergency?
Commission issues interim report with numerous calls to action, while manufacturers and distributors contend with multiple DEA penalties
It’s time for an industry guideline on patient support services
A conversation with Greg Flynn, Ashfield Healthcare US
LogiPharma meeting highlights digital transformation
Supply chain leaders gather in Philadelphia in October
Drug development in rare diseases
‘Right to try’ programs see renewed legislative attention
PDUFA reauthorization creates new pathways; GAO report notes FDA’s 99% acceptance rate for expanded access
HDA’s fourth international conference heads to Geneva
Global supply chain issues in distribution bring senior execs together
Change is a constant for sales incentive planning
Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions
New approaches to specialty distribution
A direct-distribution model could save expense for payers and patients while providing better service
ODA-designation application to approval in 19 days for Curtana Pharmaceuticals
Company is targeting a treatment for glioblastoma; Phase I to begin next year
The under-regulated world of patient services
Pharma needs better internal policies to manage its increasing patient interaction
Mylan finalizes a DoJ settlement over EpiPen pricing
Observers are critical of the $465-million penalty as too lenient
Post-approval trials of new drugs are showing limited clinical value
Is the accelerated-approval process providing a net benefit to patients?
CVS readies a set of outcomes-based contracts for its clients
Oncology, obesity control and respiratory therapy are the first targets
EMA entertains relocation bids, readies a business-continuity plan
New location, following Brexit, will be decided in November
